Jiangsu Kanion Pharmaceutical Co. Ltd. | Ownership
Companies that own Jiangsu Kanion Pharmaceutical Co. Ltd.
China Investment Corp. (Investment Management)
18,280,080
3.05%
0
0.08%
03/31/2018
Shanghai Guotai Junan Securities Assets Management Co., Ltd.
9,821,903
1.64%
9,821,903
2.93%
03/31/2018
Orient Securities Asset Management Co. Ltd.
7,009,991
1.17%
-4,500,000
0.46%
03/31/2018
Da Cheng Fund Management Co., Ltd.
5,439,480
0.91%
0
0.18%
03/31/2018
ICBC Credit Suisse Asset Management Co., Ltd.
5,439,480
0.91%
0
0.12%
03/31/2018
Harvest Fund Management Co., Ltd.
5,439,480
0.91%
0
0.06%
03/31/2018
E Fund Management Co., Ltd.
5,439,480
0.91%
0
0.06%
03/31/2018
Zhong Ou Asset Management Co., Ltd
5,439,480
0.91%
0
0.16%
03/31/2018
Bosera Asset Management Co., Ltd.
5,439,480
0.91%
-6,053,245
0.07%
03/31/2018
China Southern Asset Management Co., Ltd.
1,931,524
0.32%
-539,335
0.03%
12/31/2017
| Address |
Jiangning Industrial City
Lianyungang Jiangsu 222047
China
|
|
Employees
|
- |
| Website |
http://www.kanion.com |
| Updated |
07/08/2019 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. engages in the manufacture and sale of Chinese medicine pretreatment and extraction. It focuses on respiratory, gynecological, cardiovascular, and orthopedic disease. The company was founded on December 2, 2000 and is headquartered in Lianyungang, China. |
